IJLSSR, VOLUME 3, ISSUE 3, MAY 2017:970-972

Research Article (Open access)

Cryptococcal Peritonitis in a Patient with
Liver Cirrhosis: Case Report

Vipul Kumar Srivastava1, Areena Hoda Siddiqui2*
1MD, Consultant Microbiologist, Department of Lab Medicine, Sahara Hospital, Lucknow, India
2MD, Microbiologist, Department of Lab Medicine, Sahara Hospital, Lucknow, India

*Address for Correspondence: Dr. Areena Hoda Siddiqui, Microbiologist, Department of Lab Medicine, Sahara
Hospital, Viraj Khand, Gomti Nagar, Lucknow, India

Received: 06 January 2017/Revised: 13 February 2017/Accepted: 09 April 2017

ABSTRACT- Disseminated cryptococcosis is generally seen in immunocompromised patients mainly associated with Human Immunodeficiency Virus. Spontaneous cryptococcal peritonitis among patients of disseminated cryptococcosis is a rare presentation, which is presented in cases with cirrhosis of liver. It can be confused with spontaneous bacterial peritonitis. Strong clinical awareness and index of suspicion in a cirrhotic patient with peritonitis as well as early diagnosis and treatment is required as it is difficult to distinguish from spontaneous bacterial peritonitis. We describe here a case of disseminated cryptococcosis with cryptococcal peritonitis in a cirrhotic male
Key words: Liver cirrhosis, Cryptococcosis, Cryptococcal peritonitis

INTRODUCTION
Liver disease in a non HIV diabetic patient is an important risk factor for the cryptococcal disease. Studies have reported the prevalence of cirrhosis to be 4.5% - 9.5%.[1] According to the National Institutes of Health, cirrhosis is the 12th leading cause of death by disease.[2] Major complications of cirrhosis include ascites, variceal bleeding, hepatorenal syndrome, hepatic encephalopathy, spontaneous bacterial peritonitis, and portal hypertension. Due to immune dysregulation, uncommon pathogens become more common and virulent in these patients.[3] Because of the high morbidity and mortality, prevention, early diagnosis, and proper management of these infections are necessary to improve survival. Here we report a case of cryptococcus peritonitis in a cirrhotic male.

CASE REPORT
A 72 yrs male was admitted to our hospital with complaints of breathlessness and anasarca. His conscious level on Glasgow Coma Score scale for eye, verbal and a motor response was 10 (E3V3M4). On Examination heart rate was 70/min, SpO2 100% on oxygen, blood pressure 100/50mm of Hg, bilateral crepitus and wheezing present, abdomen tense (ascites present), S1S2 normal, pallor present, icterus present.
Laboratory examinations revealed glycosylated haemoglobin 5.4, deranged liver function test, international normalized ratio 5.69, prothrombin time 64.2 sec, sodium 116mmol/l (predictive accuracy of MELD score increases by hyponatremia which is a common finding in decompensated liver disease), potassium 5.5 mmol/l total leukocyte count was 12.71x109/L, hemoglobin 8.2g/dl, urea 201mg/dl, creatinine 4.07mg/dl. Child pughs score was 13 and MELD score was 38. Ascitic fluid routine examination revealed: cell count 800/cu mm with a predominance of neutrophils and presence of encapsulated budding yeast cell. Ascitic fluid for culture and sensitivity was sent. Gram Stain showed Gram positive budding yeast cell. India ink was positive for Cryptococcus [Fig 1]. After 48 hours of incubation, it grew mucoid colonies of Cryptococcus. Blood culture (Bactec 9120) was positive on 4th day. Colonies were identified as Cryptococcus neoformans (vitek 2 Compact, biomereux). Immediately patient was started on amphotericin B (25mg in 50ml normal saline over30min for 2days followed by75mg). Despite treatment pa-tient’s condition deteriorated, urine output decreased continuously and a patient could not survive. The death could be attributed to progressive liver failure, hepatic encephalopathy, acute on chronic kidney disease with super imposed cryptococcal peritonitis.



Fig 1: India Ink preparation showing Cryptococcus


He was admitted to our hospital five months back for fracture neck femur and upper end humerus right side. Hemiarthroplasty was done. A month later he was admitted with complains of altered sensorium, slurring of speech with per rectal bleed, ascitis and decreased urine output. He was managed conservatively and discharged in stable condition.
He was a known case of Type 2 diabetes since 14 yrs, coronary artery disease since 8 yrs, hypertension since 2 yrs and chronic liver disease since 1 year. He under went percutaneous transluminal coronary angioplasty for coronary artery disease and endoscopic variceal ligation.

DISCUSSION
Disseminated cryptococcosis is commonly found in HIV infection, solid-organ transplantation, chronic organ failure (renal and liver), immunosuppressive medications, hematologic malignancy, chronic lung disease, rheumatologic disorders, cases of gastrointestinal (GI) bleed and CAPD patients. [4-7] Cryptococcal peritonitis is seen in 7.4% of HIV cases, 2% in non HIV cases.CP is considered a rare manifestation of cryptococcosis in cirrhosis [8].
In a stud, it was found that among 33 HIV-negative patients with disseminated disease, cirrhosis was present most commonly and was also associated with grave prognosis. Leukocyte impairment, decreased opsonin activity, and complement dysfunction are known to predispose cryptococcosis in cirrhotic patients. [8] Infection of ascitic fluid (spontaneous fungal ascitis) in HIV-negative patients accounts for less than 5% of all cryptococcosis cases. Cryptococcal peritonitis is the second most common infection in patients with cirrho-sis. [9] In a study 61 cases were reviewed and cirrhosis was the major factor associated with CP. [10] Peritoneal fluid analysis reveals pleocytosis with lymphocytic predominance. Few studies have reported PMN as in our case. [9,11-12].
Very few studies from India have reported CP in decompensated liver disease. [13] The mortality rate is very high, ranging from 70 to 80%. [8,13] In our case India ink preparation was performed immediately which showed encapsulated budding yeasts. This may emphasize the need for this test to be used for initial screening in suspected cases. The patient had a MELD score of 38 and Child pughs score 13 both of which showed a poor prognosis.
Treatment of cryptococcosis depends on the site and immune status of individuals. Guidelines for CNS cryptococcosis are well established but no specific guidelines exist for treatment of cryptococcal peritonitis. [14] Prognosis in disseminated cryptococcosis with cirrhosis for HIV-negative patients with 30 day mortality is reported as 100% in one study. In HIV infected cases liver cirrhosis came out to be the strongest predictor of 30-day morality (hazard ratio 16.3). [8] In 50% of the cases the process is said to be transudative which is also seen in our case. [7]

CONCLUSIONS
We concluded in this study that spontaneous crypto-coccal peritonitis in a patient with disseminated disease is a rare manifestation of C. neoformans infection. Grave prognosis is associated in cases where cryptococcosis is present with liver cirrhosis as seen in this case. Very few cases have been reported till date. Studies regarding prophylactic treatment for a cryptococcal infection in cases where there is history of a GI bleed and liver disease should be performed to draw a consensus towards an empirical therapy.

REFERENCES
  1. Gaduputi V, Abdulsamad M, Sakam S, Abbas N, Tariq H, Ihimoyan A .Systemic vascular resistance in cirrhosis: A predictor of severity?. Hepat Med. 2014; 6: 95–101.
  2. Xu J, Kochanek KD, Murphy SL, Tejada-Vera B. Division of Vital Statistics. Deaths: Final data for 2007. Nat Vital Stat Rep. 2010; 58:1-136.
  3. Alexander R B, Chalermrat B, Reddy K R. Immune. Dysfunction and Infections in Patients with Cirrhosis. Clin Gastroenterol Hepatol. 2011; 9:727-738.
  4. Saif MW, Raj M. Cryptococcal Peritonitis Complicating Hepatic Failure: Case Report and Review of the Literature. J Appl Res. 2006; 6: 43–50.
  5. Kokturk N, Ekim N, Kervan F, Arman D, Memis L, Caglar K, et al. Disseminated cryptococcosis in a human immunodeficiency virus-negative patient: a case report. Mycoses. 2005; 48:270-274.
  6. Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ et al Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis. 2001; 33:690-699.
  7. Albert-Braun S, Venema F, Bausch J, Hunfeld KP, Schafer V. Cryptococcus neoformans peritonitis in a patient with alcoholic cirrhosis: case report and review of the literature. Infection. 2005; 33:282-288.
  8. Yehia BR, Eberlein M, Sisson SD, David NH. Disseminated cryptococcosis with meningitis, peritonitis, and cryptococcemia in a HIV-negative patient with cirrhosis: a case report. Cases Journal. 2009; 2:170.
  9. Luraschi- Monjagatta C, Alzoubaidi M, Takyar V, Assar S, Sahebjam F, Snyder L. Spontaneous Peritonitis Secondary to Cryptococcus neoformans. JSM Clin Case rep. 2014; 2:1047.
  10. El-Kersh K, Rawasia WF, Chaddha U, Guardiola J. Rarity revisited: Cryptococcal peritonitis. BMJ Case Rep. 2013: pp:1-4.
  11. Jean SS, Wang JL, Wang JT et al. Cryptococcus neoformans peritonitis in two patients with liver cirrhosis. Formos Med Assoc 2005; 104(1): 39-42.
  12. Sungkanuparph S, Vibhagool A, Pracharktam R. Spontaneous cryptococcal peritonitis in cirrhotic patients. J Postgrad Med. 2002; 48(3):201-2.
  13. Chinmaya Kumar Bal, Vikram Bhatia, Vikas Khillan, Neha Rathor, Deepak Saini, Ripu Daman, Shiv Kumar Sarin Spontaneous cryptococcal peritonitis with fungemia in patients with decompensated cirrhosis: Report of two cases. IJCCM 2014; 18(8):536-539.
  14. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. 2000; 30:710-718.

International Journal of Life-Sciences Scientific Research (IJLSSR) Open Access Policy Authors/Contributors are responsible for originality, contents, correct references, and ethical issues. IJLSSR publishes all articles under Creative Commons Attribution- Non-Commercial 4.0 International License (CC BY-NC).
https://creativecommons.org/licenses/by-nc/4.0/legalcode

How to cite this article:
Srivastava VK, Siddiqui AH: Cryptococcal Peritonitis in a Patient with Liver Cirrhosis: Case Report. Int. J. Life. Sci. Scienti. Res., 2017; 3(3): 970-972. DOI:10.21276/ijlssr.2017.3.3.1
Source of Financial Support:Nil, Conflict of interest: Nil